{"DataElement":{"publicId":"14513860","version":"1","preferredName":"Myeloma Response Disease Status","preferredDefinition":"Information related to the disease response status for myeloma.","longName":"2181321v1.00:14513859v1.00","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"2181321","version":"1","preferredName":"Myeloma Response","preferredDefinition":"information related to myeloma response.","longName":"MYE_RESP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177047","version":"1","preferredName":"Myeloma","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001) -- 2003","longName":"Myeloma","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AA0-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177336","version":"1","preferredName":"Response","preferredDefinition":"Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"Response","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528C-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Denise Warzel updated Definition by seraching NCI Thesaurus in Admin tool.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3CD6854-BEC2-42C7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14513859","version":"1","preferredName":"Disease Response Status","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._A condition or state at a particular time.","longName":"14513859v1.00","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stable disease (SD)","valueDescription":null,"ValueMeaning":{"publicId":"3859302","version":"1","preferredName":"Stable Disease","longName":"3859302","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E461EC27-2518-B912-E040-BB89AD43049F","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SOKKERL","dateModified":"2023-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06846668-0EA7-7B08-E063-731AD00A7560","beginDate":"2023-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","deletedIndicator":"No"},{"value":"Partial response (PR)","valueDescription":null,"ValueMeaning":{"publicId":"3951935","version":"1","preferredName":"Partial Remission","longName":"3951935","preferredDefinition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5B7-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06846668-0EA8-7B08-E063-731AD00A7560","beginDate":"2023-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","deletedIndicator":"No"},{"value":"Very good partial response (VGPR)","valueDescription":null,"ValueMeaning":{"publicId":"3669391","version":"1","preferredName":"Very good Partial Response","longName":"3669391","preferredDefinition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Very Good Partial Response","conceptCode":"C123618","definition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4813252-CCB5-71BE-E040-BB89AD4341ED","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Added concept annotation. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06846668-0EA9-7B08-E063-731AD00A7560","beginDate":"2023-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","deletedIndicator":"No"},{"value":"Complete response (CR)","valueDescription":null,"ValueMeaning":{"publicId":"3951936","version":"1","preferredName":"Complete Remission","longName":"3951936v1.00","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5DA-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SOKKERL","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06846668-0EAA-7B08-E063-731AD00A7560","beginDate":"2023-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","deletedIndicator":"No"},{"value":"Complete response/stringent complete response (CR/sCR)","valueDescription":null,"ValueMeaning":{"publicId":"14596560","version":"1","preferredName":"Complete Remission And/Or Stringent Complete Response","longName":"14596560v1.00","preferredDefinition":"The disappearance of all signs of cancer in response to treatment._Used to indicate that either or both of two items or options may be valid._The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stringent Complete Response","conceptCode":"C123614","definition":"The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0942C6C6-B9EB-7A53-E063-731AD00A17D1","latestVersionIndicator":"Yes","beginDate":"2023-11-03","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-11-03","modifiedBy":"ZHWENDY","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0942C6C6-B9EC-7A53-E063-731AD00A17D1","beginDate":"2023-11-03","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-11-03","modifiedBy":"ZHWENDY","dateModified":"2023-11-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6612626","version":"1","preferredName":"Disease Response Status","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:A condition or state at a particular time.","longName":"C50995:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F861447-6ADE-182F-E053-F662850A17F5","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06845ACB-078C-7955-E063-731AD00AA5BE","latestVersionIndicator":"Yes","beginDate":"2023-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-29","modifiedBy":"ZHWENDY","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":"2023.9.29 Created per ticket request CADSR0002904. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the disease response status for myeloma?","url":null,"context":"Alliance"},{"name":"Alliance Text 1","type":"Alternate Question Text","description":"Response status prior to randomization:","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0684814A-366F-7F08-E063-731AD00AE143","latestVersionIndicator":"Yes","beginDate":"2023-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-29","modifiedBy":"ZHWENDY","dateModified":"2023-10-23","changeDescription":null,"administrativeNotes":"2023.9.29 Created per ticket request CADSR0002904. ak","unresolvedIssues":null,"deletedIndicator":"No"}}